TD Waterhouse Canada’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Sell |
229,861
-39,277
| -15% | -$1.87M | 0.08% | 183 |
|
|
2025
Q1 | $16M | Sell |
269,138
-1,175
| -0.4% | -$69.9K | 0.13% | 137 |
|
|
2024
Q4 | $15.3M | Buy |
270,313
+16,293
| +6% | +$922K | 0.12% | 145 |
|
|
2024
Q3 | $13.4M | Buy |
254,020
+136,877
| +117% | +$7.24M | 0.11% | 157 |
|
|
2024
Q2 | $4.84M | Sell |
117,143
-154,499
| -57% | -$6.39M | 0.04% | 246 |
|
|
2024
Q1 | $15M | Sell |
271,642
-14,788
| -5% | -$818K | 0.11% | 151 |
|
|
2023
Q4 | $16.2M | Sell |
286,430
-95,438
| -25% | -$5.41M | 0.15% | 116 |
|
|
2023
Q3 | $23.1M | Sell |
381,868
-20,890
| -5% | -$1.26M | 0.24% | 79 |
|
|
2023
Q2 | $27.1M | Buy |
402,758
+213,282
| +113% | +$14.3M | 0.27% | 71 |
|
|
2023
Q1 | $14.3M | Sell |
189,476
-5,673
| -3% | -$428K | 0.15% | 112 |
|
|
2022
Q4 | $15.4M | Buy |
195,149
+867
| +0.4% | +$68.3K | 0.17% | 98 |
|
|
2022
Q3 | $14.9M | Buy |
194,282
+31,125
| +19% | +$2.38M | 0.17% | 97 |
|
|
2022
Q2 | $13.5M | Sell |
163,157
-3,692
| -2% | -$306K | 0.15% | 99 |
|
|
2022
Q1 | $13.1M | Buy |
166,849
+2,247
| +1% | +$177K | 0.13% | 111 |
|
|
2021
Q4 | $10.9M | Buy |
+164,602
| New | +$10.9M | 0.11% | 133 |
|